Skip to main content
SpringerLink
Log in

The impact of pneumococcal conjugate vaccine on the prevalence and severity of hospitalizations for pneumonia in children

  • Original Article
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Pneumococcal conjugate vaccines (PCV) were introduced into the Israeli national immunization plan starting with the heptavalent PCV7 in 2009 and then PCV13 in the late 2010. The objective of this study was to determine the vaccines’ impact on hospitalization rates for community-acquired pneumonia on the severity of the pneumonia episodes and upon pneumococcal serotype distribution. We retrospectively reviewed all children hospitalized in our institution with pneumonia, aged between 1 and 16 years, between the years 2006 and 2015. Demographic, clinical, and laboratory data between three time periods: pre-PCV, PCV7, and PCV13, were compared. During the study period, 1375 children were hospitalized with pneumonia. A gradual decline in hospitalization rates due to pneumonia was observed starting in 2006 in the pre-PCV period and continued until after the introduction of PCV13. A similar trend was observed in pneumonias with a culture positive for S. pneumoniae. Pleural effusion was observed in 24% of all pneumonias, and this percentage was stable throughout the study period. The average age at hospitalization increased during the study period, as did the average duration of hospital stay. Pneumococcal serotypes included in the vaccine were isolated less frequently during the study and non-vaccine serotypes tended to appear more frequently. Pediatric pneumonia hospitalization rates continued to decline since the introduction of PCV without increasing the frequency of complications. Pneumococcal serotype distribution shifted in parallel. Our findings confirm the efficacy of PCV and support the evidence to include more serotypes in the next generation of PCV.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

All data is available on request from the corresponding author.

Code availability

Not applicable.

References

  1. O’Brien KL, Wolfson LJ, Watt JP et al (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:893–902

    Article  Google Scholar 

  2. Neuman MI, Hall M, Lipsett SC et al (2017) Pediatric Research in Inpatient Settings Network. Utility of blood culture among children hospitalized with community-acquired pneumonia. Pediatrics. 140(3):e20171013

    Article  Google Scholar 

  3. Ruiz-González A, Falguera M, Nogués A et al (1999) Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. Am J Med 106:385–390

    Article  Google Scholar 

  4. Juven T, Mertsola J, Waris M et al (2000) Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 19:293–298

    Article  CAS  Google Scholar 

  5. Ben-Shimol S, Greenberg D, Givon-Lavi N et al (2014) Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance. Vaccine 32:3452–3459

    Article  Google Scholar 

  6. Tan TQ (2012) Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 25:409–419

    Article  Google Scholar 

  7. Isaacman DJ, McIntosh ED, Reinert RR (2010) Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 14:e197-209

    Article  Google Scholar 

  8. Feikin DR, Kagucia EW, Loo JD et al (2013) Serotype Replacement Study Group. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 10:e1001517

    Article  Google Scholar 

  9. Kaplan SL, Barson WJ, Lin PL et al (2013) Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 32:203–207

    Article  Google Scholar 

  10. Myers AL, Hall M, Williams DJ et al (2013) Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia. Pediatr Infect Dis J 32:736–740

    Article  Google Scholar 

  11. Olarte L, Barson WJ, Barson RM et al (2017) Pneumococcal pneumonia requiring hospitalization in US children in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis 64:1699–1704

    Article  Google Scholar 

  12. Lindstrand A, Bennet R, Galanis I et al (2014) Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine. Pediatrics 134:e1528-1536

    Article  Google Scholar 

  13. Pírez MC, Algorta G, Chamorro F et al (2014) Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay. Pediatr Infect Dis J 33:753–759

    Article  Google Scholar 

  14. Greenberg D, Givon-Lavi N, Ben-Shimol S, Ziv JB, Dagan R (2015) Impact of PCV7/PCV13 introduction on community-acquired alveolar pneumonia in children <5 years. Vaccine 33:4623–4629

    Article  Google Scholar 

  15. Saxena S, Atchison C, Cecil E et al (2015) Additive impact of pneumococcal conjugate vaccines on pneumonia and empyema hospital admissions in England. J Infect 71:428–436

    Article  Google Scholar 

  16. Nath S, Thomas M, Spencer D et al (2015) Has the incidence of empyema in Scottish children continued to increase beyond 2005? Arch Dis Child 100:255–258

    Article  Google Scholar 

  17. Strachan RE, Snelling TL, Jaffé A (2013) Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine. Bull World Health Organ 91:167–173

    Article  Google Scholar 

  18. Grijalva CG, Nuorti JP, Zhu Y et al (2010) Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis 50:805–813

    Article  Google Scholar 

  19. Fletcher MA, Schmitt HJ et al (2014) Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology. Eur J Clin Microbiol Infect Dis 33:879–910

    Article  CAS  Google Scholar 

  20. Hendrickson DJ, Blumberg DA, Joad JP et al (2008) Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 27:1030–1032

    Article  Google Scholar 

  21. Triadou D, Givon-Lavi N, Greenberg D et al (2020) Pneumococcal conjugate vaccines decrease community-acquired alveolar pneumonia with and without pleural effusion in children <60 months in Southern Israel 2002–2016. Infect Dis (Lond) 52:186–195

    Article  Google Scholar 

  22. Wiese AD, Griffin MR, Zhu Y et al (2016) Changes in empyema among US children in the pneumococcal conjugate vaccine era. Vaccine 34:6243–6249

    Article  Google Scholar 

  23. Bernaola E, Herranz M, Gil-Setas A et al (2018) Pneumococcal vaccination and Pneumonia associated with pleural effusion in a pediatric population. Pediatr Infect Dis J. 37(4):e87–e92

    Article  Google Scholar 

  24. Rokney A, Ben-Shimol S, Korenman Z et al (2018) Emergence of Streptococcus pneumoniae serotype 12F after sequential introduction of 7- and 13-valent vaccines, Israel. Emerg Infect Dis 24:453–461

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Noam Eichler and Leon Joseph contributed equally as co-first authors

Authors and Affiliations

  1. Pediatric Pulmonology Institute, Shaare Zedek Medical Center, affiliated with The Hebrew University, School of Medicine, Jerusalem, Israel

    Noam Eichler, Leon Joseph, Shmuel Goldberg & Elie Picard

  2. Pediatric Infectious Unit, Shaare Zedek Medical Center, affiliated with The Hebrew University, School of Medicine, Jerusalem, Israel

    Orli Megged

Authors
  1. Noam Eichler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leon Joseph
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Orli Megged
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shmuel Goldberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elie Picard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elie Picard.

Ethics declarations

Ethics approval

This study was approved by the local ethics committee.

Consent to participate

Consent to participate was waived by ethics committee.

Consent for publication

This study did not require institutional consent for publication.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eichler, N., Joseph, L., Megged, O. et al. The impact of pneumococcal conjugate vaccine on the prevalence and severity of hospitalizations for pneumonia in children. Eur J Clin Microbiol Infect Dis 41, 439–444 (2022). https://doi.org/10.1007/s10096-021-04386-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-021-04386-0

Keywords

Search

Navigation